Respiratory Syncytial Virus vaccine in infants and toddlers.

Evaluate the efficacy, immunogenicity, and safety of a Respiratory Syncytial Virus vaccine in infancy and toddlers.

» Study Details | Apply for the Study

Symptoms of Schizophrenia

Do you have negative symptoms of schizophrenia? You could be eligible for a study of mobile apps

» Study Details | Apply for the Study

DIABETIC PERIPHERAL NEUROPATHIC PAIN

A PHASE 2 STUDY TO EVALUATE THE SAFETY AND EFFICACY OF RTA 901 IN PATIENTS WITH DIABETIC PERIPHERAL NEUROPATHIC PAIN

» Study Details | Apply for the Study

Participants with Type 2 Diabetes and Obesity

Investigational Tirzepatide Doses in Participants with Type 2 Diabetes and Obesity

» Study Details | Apply for the Study

Upcoming Studies for Men & Women

» Study Details | Apply for the Study

assessment of estradiol and progesterone in saliva in females during their

Primary • Assess the clinical performance of the Emblem Test in ovulation confirmation, and measurement of quantitative estradiol, and progesterone analytes

Secondary • Assess the clinical performance of the Emblem Test in prediction of Menstruation Onset

» Study Details | Apply for the Study

TAK-062-2001 Treatment of Active Celiac Disease in Subjects Attempting a Gl

Participants are needed for the ILLUMINATE-062 Study, which is looking at the safety and effectiveness of an investigational medication designed to break down gluten in the stomach compared with placebo in those with celiac disease who are on a gluten-free diet. The study will evaluate how well the investigational medication reduces celiac-related symptoms and intestinal damage due to gluten exposure.   Participants who have been diagnosed with celiac, which was confirmed by a biopsy, and have been on a gluten-free diet for at least 12 months are needed. Study-related care is provided at no cost, and a travel stipend may be provided.

» Study Details | Apply for the Study

Prevention of Gluten-Specific T Cell Activation in Subjects with Celiac Dis

The ILLUMINATE-101 clinical research study is evaluating the safety and effectiveness of an investigational medication designed to reduce or eliminate the negative immune response to gluten in adults with celiac disease and participants are needed.

» Study Details | Apply for the Study

Women of Childbearing Potential to Evaluate Contraceptive Efficacy and Safe

A Phase 3, Multicenter, Open-Label, Single Arm Study of MR-100A-01 in Women of Childbearing Potential to Evaluate Contraceptive Efficacy and Safety

» Study Details | Apply for the Study

Combination Therapy in Women with Uterine Fibroids or Endometriosis who are

Study of the Safety and Contraceptive Efficacy of Relugolix Combination Therapy in Women with Uterine Fibroids or Endometriosis who are at Risk for Pregnancy

» Study Details | Apply for the Study

Uterine Fibroids or Moderate to Severe Pain Associated with Endometriosis

Open-Label Study to Evaluate Bone Mineral Density with Long-Term Use of Relugolix Combination Tablet in Premenopausal Women with Heavy Menstrual Bleeding Associated with Uterine Fibroids or Moderate to Severe Pain Associated with Endometriosis

» Study Details | Apply for the Study

Non-Hormonal Pharmacotherapies Among Individuals Treated for Bothersome Vas

Non-Hormonal Pharmacotherapies Among Individuals Treated for Bothersome Vasomotor Symptoms

» Study Details | Apply for the Study

TREATMENT OF ACUTE UNCOMPLICATED INFLUENZA-LIKE ILLNESS

A PHASE 2B DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY OF THE EFFICACY AND SAFETY OF NORKETOTIFEN IN THE TREATMENT OF ACUTE UNCOMPLICATED INFLUENZA-LIKE ILLNESS (ILI)

» Study Details | Apply for the Study

A Study to Evaluate the Efficacy and Safety of VYD222 for Prevention of COV

A Study to Evaluate the Efficacy and Safety of VYD222 for Prevention of COVID-19 (CANOPY)

» Study Details | Apply for the Study

COVID-19 AND INFLUENZA IN HEALTHY INDIVIDUALS Vaccine Study

COVID-19 AND INFLUENZA IN HEALTHY INDIVIDUALS Combo Vaccine Study

» Study Details | Apply for the Study